BASES FOR THE EARLY IMMUNE-RESPONSE AFTER RECHALLENGE OR COMPONENT VACCINATION IN AN ANIMAL-MODEL OF ACUTE MYCOPLASMA-PNEUMONIAE PNEUMONITIS

被引:14
作者
CIMOLAI, N
MAH, DG
TAYLOR, GP
MORRISON, BJ
机构
[1] UNIV BRITISH COLUMBIA,DEPT PATHOL,DIV MED MICROBIOL,VANCOUVER,BC,CANADA
[2] UNIV BRITISH COLUMBIA,DEPT HLTH CARE & EPIDEMIOL,VANCOUVER,BC,CANADA
关键词
MYCOPLASMA PNEUMONIAE; PNEUMONIA; PATHOLOGY;
D O I
10.1016/0264-410X(95)93318-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathology of Mycoplasma pneumoniae pulmonary infection for a hamster model was examined after whole bacterium rechallenge or component vaccination. Animals which, after an initial infection, were rechallenged with either live or heat-killed M. pneumoniae inocula developed severe early recall lesions in the first 3 days. In contrast, animals infected once develop maximum histopathology at approximately 10-14 days. A severe perivascular inflammatory cellular infiltrate developed in the rechallenged groups, and pulmonary pathology could also be elicited by rechallenge with bacterial growth medium components. Component vaccination with protein P1 did not reduce disease in comparison to once-infected controls, and vaccination promoted art early immune recall response as well. We conclude that art early immune response needs to be sought in all future experiments of challenge/rechallenge or vaccination. Vaccine studies will require an understanding of both protective and harmful immunogens.
引用
收藏
页码:305 / 309
页数:5
相关论文
共 22 条
[1]   HAMSTER CHALLENGE POTENCY ASSAY FOR EVALUATION OF MYCOPLASMA-PNEUMONIAE VACCINES [J].
BARILE, MF ;
CHANDLER, DKF ;
YOSHIDA, H ;
GRABOWSKI, MW ;
RAZIN, S .
INFECTION AND IMMUNITY, 1988, 56 (09) :2450-2457
[2]  
CIMOLAI N, 1989, J RHEUMATOL, V16, P1150
[3]   DEFINITION AND APPLICATION OF A HISTOPATHOLOGICAL SCORING SCHEME FOR AN ANIMAL-MODEL OF ACUTE MYCOPLASMA-PNEUMONIAE PULMONARY INFECTION [J].
CIMOLAI, N ;
TAYLOR, GP ;
MAH, D ;
MORRISON, BJ .
MICROBIOLOGY AND IMMUNOLOGY, 1992, 36 (05) :465-478
[4]   IMMUNOLOGICAL CROSS-REACTIVITY OF A MYCOPLASMA-PNEUMONIAE MEMBRANE-ASSOCIATED PROTEIN ANTIGEN WITH MYCOPLASMA-GENITALIUM AND ACHOLEPLASMA-LAIDLAWII [J].
CIMOLAI, N ;
BRYAN, LE ;
TO, M ;
WOODS, DE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (11) :2136-2139
[5]   IGM ANTI-P1 IMMUNOBLOTTING - A STANDARD FOR THE RAPID SEROLOGIC DIAGNOSIS OF MYCOPLASMA-PNEUMONIAE INFECTION IN PEDIATRIC CARE [J].
CIMOLAI, N ;
CHEONG, ACH .
CHEST, 1992, 102 (02) :477-481
[6]   IMMUNOPATHOLOGY OF EXPERIMENTAL MYCOPLASMA-PNEUMONIAE DISEASE [J].
CLYDE, WA .
INFECTION AND IMMUNITY, 1971, 4 (06) :757-+
[7]   EXPERIMENTAL INFECTION WITH MYCOPLASMA PNEUMONIAE (EATONS AGENT) [J].
DAJANI, AS ;
CLYDE, WA ;
DENNY, FW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1965, 121 (06) :1071-&
[8]  
FERNALD G W, 1970, Infection and Immunity, V1, P559
[9]  
FERNALD GW, 1972, J IMMUNOL, V108, P1400
[10]   ROLE OF HUMORAL ANTIBODIES IN RESISTANCE TO MYCOPLASMA-PNEUMONIAE PNEUMONIA IN HAMSTERS [J].
HAYATSU, E ;
KAWAKUBO, Y ;
YAYOSHI, M ;
ARAAKE, M ;
YOSHIOKA, M ;
NISHIYAMA, Y .
MICROBIOLOGY AND IMMUNOLOGY, 1980, 24 (07) :585-593